Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes
published in: Diabetes Care
date of publication: 2006-07-01
language: English
main subject: type 2 diabetes, atherosclerosis, preproinsulin
Cites articles
There is nothing here
Article - wd:Q46083123